Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00269061|
Recruitment Status : Completed
First Posted : December 23, 2005
Last Update Posted : October 16, 2008
|Condition or disease||Intervention/treatment||Phase|
|Non-Insulin-Dependent Diabetes Mellitus||Drug: pioglitazone||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||32 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||An Exploratory MRI Study in Type 2 Diabetic Subjects: A Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Measurement of Fluid Volumes by MRI in the Lower Extremities of Subjects Receiving Pioglitazone|
|Study Start Date :||January 2006|
- Changes in interstitial fluid volume in the lower extremities as measured by MRI.
- Assessments of other indicators of fluid volume changes, including labwork evaluation, fluid compartment volume measurement, direct measurement of the calf.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00269061
|United States, Massachusetts|
|GSK Investigational Site|
|Belmont, Massachusetts, United States, 02478|
|Study Director:||GSK Clinical Trials, MD||GlaxoSmithKline|